Lamilept

Lamotrigine, the active ingredient in Lamilept, is an anticonvulsant presented as a strength/form for oral use. It treats epilepsy, including partial and generalized tonic‑clonic seizures, and serves as maintenance therapy for bipolar disorder in adults and children as prescribed.

GNH USA supplies Lamilept as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lamotrigine is employed in the management of seizure disorders and mood stabilization therapies. - Epilepsy: reduces the frequency and severity of partial and generalized tonic‑clonic seizures. - Bipolar disorder: provides maintenance treatment to help prevent mood swings and depressive episodes. - Partial seizures: controls focal seizure activity when other agents are insufficient.

Lamotrigine may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Dizziness - Headache - Nausea or vomiting - Skin rash - Blurred vision - Insomnia

Serious or Rare Side Effects: - Stevens‑Johnson syndrome or toxic epidermal necrolysis - Severe skin reactions (e.g., drug reaction with eosinophilia and systemic symptoms) - Blood dyscrasias such as agranulocytosis - Hepatic failure - Suicidal thoughts or behavior - Severe hypersensitivity reactions

When prescribing Lamilept, clinicians should consider several safety measures. - Monitor blood counts: regular CBC testing is advised. - Assess hepatic function: liver enzymes should be checked before and during therapy. - Adjust dose in renal impairment: dose reduction may be required. - Avoid abrupt discontinuation: taper gradually to reduce seizure risk. - Use caution in pregnancy: benefits must outweigh potential risks. - Store at below 25°C: keep in the original packaging, protect from moisture.

Lamotrigine interacts with several medications that can alter its plasma levels or increase toxicity.

Major Interactions (Avoid): - Valproic acid: markedly increases lamotrigine concentrations. - Carbamazepine: significantly reduces lamotrigine levels. - Phenytoin: decreases lamotrigine exposure. - Phenobarbital: lowers lamotrigine concentrations. - Oral contraceptives: increase lamotrigine clearance, reducing efficacy.

Moderate Interactions (Monitor Closely): - Serotonergic agents: potential for serotonin syndrome. - NSAIDs: may raise risk of skin rash. - Antidepressants: monitor for mood changes. - Antacids: can affect lamotrigine absorption. - Alcohol: may enhance central nervous system depression.